EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Digital Surveillance After Allogeneic Hematopoietic Stem Cell Transplantation Guides Therapeutic Interventions to Reduce Non‐Relapse Mortality

Lara Bischof, Katharina Egger-Heidrich, Martin Schneider, Gregor Friedrich iD, Anna Massow, Johanna Vogelsang, Franziska Schmidt, Matthias Hänel iD, Thomas Illmer, Lynn Leppla, Alexandra Teynor, Sabina de Geest iD und 6 weitere

European Journal of Haematology · 2026-06 · 116 (6) · 937-942

DOI: 10.1111/ejh.70159 ↗

Kurz gefasst

Fallbericht in der Zeitschrift European Journal of Haematology, online erschienen am 18.03.2026. Verfasst von Lara Bischof und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department for Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University of Leipzig Medical Center, Leipzig, Germany. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Leukemia, Myeloid, Acute. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 'Gemeinsamer Bundesausschuss' of Germany.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Allogeneic hematopoietic stem cell transplantation (HSCT) offers curative potential for many hematological malignancies; however, outcomes may be adversely affected by infections and transplant‐associated complications, contributing to non‐relapse mortality (NRM). Innovative digital approaches for outpatient surveillance may support earlier detection of complications and thereby help reduce NRM. Case Presentation We report on a 73 year‐old Caucasian patient who underwent allogeneic HSCT for acute myeloid leukemia in complete remission following non‐myeloablative conditioning. The patient participated in the interventional study “Cross‐sectoral care for patients with hematological diseases following innovative cell therapy” (SPIZ), which evaluates digital surveillance after cellular therapies. SPIZ comprises daily remote monitoring of vital signs, medication adherence, and symptoms using a multimodal approach integrating an eHealth system (patient smartphone app and caregiver monitoring dashboard), home visits, video consultations, and regular case conferences with referring physicians during follow‐up. Eight months post‐HSCT, during an inpatient stay at an orthopedic rehabilitation center, the patient reported increasing dyspnea and cough via the app. In response, the SPIZ team initiated immediate transfer to the transplant center. Diagnostic work‐up revealed pneumonia caused by aspergillus fumigatus and coronavirus, and progression of pre‐existing pulmonary graft‐versus‐host disease (GvHD), confirmed by computed tomography and spiroergometry. Early detection and prompt transfer enabled rapid initiation of antifungal therapy and intensified GvHD management. The patient was discharged with improved general condition and respiratory function, without further septic complications.

Conclusion

Innovative digital surveillance is an effective tool for outpatient monitoring after cellular therapies, facilitating early detection and intervention and potentially reducing NRM, particularly in high‐risk patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationLeukemia, Myeloid, AcuteAgedHumansCOVID-19Digital HealthGraft vs Host DiseaseRemote Patient MonitoringTransplantation, Homologous

Stichwörter der Autor:innen

acute myeloid leukemiaallogeneic HSCTdigital surveillance

Autor:innen und Institutionen

  • Department for Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University of Leipzig Medical Center, Leipzig, Germany.
  • Cancer Center Central Germany-CCCG, Leipzig, Germany.
  • Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
  • Clinical Trials Unit, DKMS Group, Dresden, Germany.
  • Department of Internal Medicine III, Hospital Chemnitz, Chemnitz, Germany.
  • Private Practice Hematology and Oncology, Dresden, Germany.

ORCID-Profile: Gregor Friedrich, Matthias Hänel, Sabina de Geest

Förderung

  • 'Gemeinsamer Bundesausschuss' of Germany

Zitieren

APA

Bischof, L., Egger-Heidrich, K., Schneider, M., Friedrich, G., Massow, A., Vogelsang, J., Schmidt, F., Hänel, M., Illmer, T., Leppla, L., Teynor, A., de Geest, S., Muelller, G., Metzeler, K. H., Bornhäuser, M., Platzbecker, U., Middeke, J. M., & Vučinić, V. (2026). Digital Surveillance After Allogeneic Hematopoietic Stem Cell Transplantation Guides Therapeutic Interventions to Reduce Non‐Relapse Mortality. European Journal of Haematology, 116(6), 937-942. https://doi.org/10.1111/ejh.70159

Vancouver

Bischof L, Egger-Heidrich K, Schneider M, Friedrich G, Massow A, Vogelsang J, et al. Digital Surveillance After Allogeneic Hematopoietic Stem Cell Transplantation Guides Therapeutic Interventions to Reduce Non‐Relapse Mortality. European Journal of Haematology. 2026;116(6):937-942. doi:10.1111/ejh.70159

BibTeX
@article{Bischof2026,
  author = {Bischof, Lara and Egger-Heidrich, Katharina and Schneider, Martin and Friedrich, Gregor and Massow, Anna and Vogelsang, Johanna and Schmidt, Franziska and Hänel, Matthias and Illmer, Thomas and Leppla, Lynn and Teynor, Alexandra and de Geest, Sabina and Muelller, Gabriele and Metzeler, Klaus H and Bornhäuser, Martin and Platzbecker, Uwe and Middeke, Jan Moritz and Vučinić, Vladan},
  title = {Digital Surveillance After Allogeneic Hematopoietic Stem Cell Transplantation Guides Therapeutic Interventions to Reduce Non‐Relapse Mortality},
  journal = {European Journal of Haematology},
  year = {2026},
  volume = {116},
  number = {6},
  pages = {937--942},
  doi = {10.1111/ejh.70159}
}
Kostenlos starten →